Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $36117.0.

  • Gain Therapeutics' Other Non-Current Assets rose 662.47% to $36117.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $36117.0, marking a year-over-year increase of 662.47%. This contributed to the annual value of $32109.0 for FY2024, which is 562.01% down from last year.
  • Per Gain Therapeutics' latest filing, its Other Non-Current Assets stood at $36117.0 for Q3 2025, which was up 662.47% from $36278.0 recorded in Q2 2025.
  • Gain Therapeutics' 5-year Other Non-Current Assets high stood at $86998.0 for Q3 2021, and its period low was $28859.0 during Q3 2022.
  • Over the past 5 years, Gain Therapeutics' median Other Non-Current Assets value was $31816.0 (recorded in 2023), while the average stood at $38999.1.
  • As far as peak fluctuations go, Gain Therapeutics' Other Non-Current Assets crashed by 6682.8% in 2022, and later skyrocketed by 1407.1% in 2025.
  • Gain Therapeutics' Other Non-Current Assets (Quarter) stood at $31279.0 in 2021, then dropped by 1.47% to $30818.0 in 2022, then rose by 10.39% to $34021.0 in 2023, then dropped by 5.62% to $32109.0 in 2024, then increased by 12.48% to $36117.0 in 2025.
  • Its Other Non-Current Assets was $36117.0 in Q3 2025, compared to $36278.0 in Q2 2025 and $32641.0 in Q1 2025.